PET-CT detection of local residual laryngeal carcinoma after definitive

• Published in: BMC cancer Vol. 23; no. 1
• Main Authors: Aro, Katri, Sistonen, Heli J, Ilmarinen, Taru, Atula, Timo, Schildt, Jukka, Markkola, Antti
• Format: Journal Article
• Language: English
• Published: BioMed Central Ltd 18.04.2023
• Subjects: Analysis; Cancer; Care and treatment; Chemotherapy; CT imaging; Diagnosis; Laryngeal cancer; Patient outcomes; PET imaging; Radiotherapy; Relapse; Finland
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-023-10834-1

Background Positron emission tomography and computed tomography (PET-CT) is currently recommended in evaluating the treatment response after (chemo)radiotherapy ([C]RT). In the larynx, post-treatment changes and physiological uptake make image interpretation more challenging compared to other head and neck sites. Previous research has not addressed imaging factors specifically in the larynx that would help in distinguishing the residual disease and explain the unique challenges of that anatomic area. The study cohorts are small and heterogenous. Our objective was to investigate the ability of PET-CT in diagnosing local residual laryngeal carcinoma, and to uncover imaging factors that could be used in differentiating the residual disease from post-treatment and physiological changes. In the same study cohort, we also aimed to uncover prognostic factors for local residual or recurrent disease. Methods Our retrospective study cohort included 73 patients with T2-T4 laryngeal carcinoma undergoing (C)RT with curative intention, and post-treatment non-contrast-enhanced PET-CT at 2-6 months. Findings were compared between local residual and non-residual disease. Local residual disease was defined as a persistent tumor growth with no evidence of remission in between, confirmed by biopsy, and evident within 6 months from the end of RT. PET-CT was evaluated using a 3-step scale: negative, equivocal, and positive. Results Nine (12%) had a local residual tumor and 11 (15%) developed local recurrence, based on the biopsy. The median follow-up of surviving patients was 64 months (range, 28-174). In univariate analysis, primary tumor diameter greater than 2.4 cm (median value), and vocal cord fixation were prognostic for local residual or recurrent disease. Sensitivity, specificity, PPV, and NPV were 100%, 75%, 36%, and 100%, respectively, when the equivocal interpretation was grouped with the positive interpretation. All local residuals, and 28% (18/64) non-residuals, had a primary tumor area SUV.sub.max of over 4.0 (p < 0.001). CT showed a persistent mass at the primary tumor area in 56% of residuals, and in 23% of non-residuals (p > 0.05). By combining SUV.sub.max4.0 and mass, specificity improved to 91%. Conclusions NPV of post-treatment PET-CT in laryngeal carcinoma is high, but equivocal and positive results have low PPV and require further diagnostics. All local residuals had SUV.sub.max over 4.0. The combination of SUV.sub.max over 4.0 and mass on CT increased specificity, but the sensitivity was low. Keywords: Positron emission tomography and computed tomography, Post-treatment, Chemoradiotherapy, Imaging, Head and neck cancer